3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors

RS68111B1Active Publication Date: 2026-06-30ORYZON GENOMICS SA

Patent Information

Authority / Receiving Office
RS · RS
Patent Type
Patents
Current Assignee / Owner
ORYZON GENOMICS SA
Filing Date
2020-06-05
Publication Date
2026-06-30
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.